Oncodesign Precision Medicine
€0.2790
8
+€0.05+22.91% 19:31 Today
Statistics
Day High
0.295
Day Low
0.225
52W High
0.892
52W Low
0.1925
Volume
50
Avg. Volume
-
Mkt Cap
5.16M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
30AprExpected
Q2 2025
Q1 2026
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A
Financials
2,099.62%Profit Margin
Profitable261,000Revenue
5.48MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ZR8.STU. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Oncodesign Precision Medicine Société anonyme, a biopharmaceutical company, engages in the precision medicine business. The company's product pipeline consist of OPM-101, a RIPK2 inhibitor for the treatment of inflammatory bowel disease and immuno-oncology; OPM-102 to treat cancer; and OPM-201, a LRRK2 inhibitor for the treatment of Parkinson's disease. It also focuses on the development of a radiotheranostic molecule portfolio for the diagnosis and the treatment of advanced digestive cancers, as well as on developing treatment for pancreatic and other cancers. Oncodesign Precision Medicine Société anonyme was founded in 1995 and is based in Dijon, France.
Show more...
CEO
Dr. Philippe Genne Ph.D.
Employees
13
Country
France
ISIN
FR001400CM63
WKN
000A3DVNM
Listings
0 Comments
Share your thoughts
FAQ
What is Oncodesign Precision Medicine stock price today?▼
The current price of ZR8.STU is €0.28 EUR — it has increased by +22.91% in the past 24 hours. Watch Oncodesign Precision Medicine stock price performance more closely on the chart.
What is Oncodesign Precision Medicine stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Oncodesign Precision Medicine stocks are traded under the ticker ZR8.STU.
Is Oncodesign Precision Medicine stock price growing?▼
ZR8.STU stock has risen by +36.1% compared to the previous week, the month change is a -7.62% fall, over the last year Oncodesign Precision Medicine has showed a -43.18% decrease.
What is Oncodesign Precision Medicine market cap?▼
Today Oncodesign Precision Medicine has the market capitalization of 5.16M
What is Oncodesign Precision Medicine revenue for the last year?▼
Oncodesign Precision Medicine revenue for the last year amounts to 261,000 EUR.
What is Oncodesign Precision Medicine net income for the last year?▼
ZR8.STU net income for the last year is 5.48M EUR.
How many employees does Oncodesign Precision Medicine have?▼
As of September 24, 2026, the company has 13 employees.
In which sector is Oncodesign Precision Medicine located?▼
Oncodesign Precision Medicine operates in the Health & Wellness sector.
When did Oncodesign Precision Medicine complete a stock split?▼
Oncodesign Precision Medicine has not had any recent stock splits.
Where is Oncodesign Precision Medicine headquartered?▼
Oncodesign Precision Medicine is headquartered in Dijon, France.